ASRM 2007 Annual Meeting

Contraception Day Program
Tuesday, October 16, 2007

All Rooms Located in the Washington Convention Center unless otherwise noted.

SPECIAL SESSION
Room 201 
7:00 a.m.-7:55 a.m.

Introduction: Significance of Hormonal Contraception
Vanessa Cullins, MD, MPH, MBA
Vice President for Medical Affairs, Planned Parenthood Federation of America

Contraception: Putting the Risks in Perspective
Carolyn Westhoff, MD
Professor of Obstetrics and Gynecology, Professor of Epidemiology and Population and Family Health; Director, Division of Family Planning and Preventive Services, College of Physicians and Surgeons, Columbia University in the City of New York

Supported by an Educational Grant from Ortho Women’s Health

Needs Assessment & Symposium Description: 
In recent years, new delivery systems and new regimens for hormonal contraceptive agents have been developed to improve compliance and potential adverse events. New methods of hormonal contraception require careful assessment of efficacy and safety. The availability of new delivery systems and new dosing regimens has brought a resurgence of public scrutiny of hormonal contraception in general with attention focused on possible side effects. This presents the need to put the risks into perspective for the prescribing healthcare professional. All forms of contraception have risks and benefits. This program will provide specialists in reproductive medicine, family planning and gynecology with a broad overview of safety and efficacy profiles for all currently utilized delivery methods for hormonal contraceptives. 

Learning Objectives: 
At the conclusion of the Symposium, participants should be able to: 

1. Compare the risks and benefits of various hormonal contraceptive methods. 

2. Discuss the safety and efficacy profiles for all currently utilized delivery methods and dosing regimens for hormonal contraceptives. 

CONTRACEPTION DAY KEYNOTE SPEAKER
Room 201 
10:15 a.m. -11:00 a.m.

THE COCHRANE FERTILITY REGULATION GROUP: SYNTHESIZING THE BEST EVIDENCE ABOUT FAMILY PLANNING
David A. Grimes, M.D.

CONTRACEPTION SYMPOSIUM
Room 201 
11:00 a.m. - 12:00 p.m.

THE POLITICS OF CONTRACEPTION
Moderator: Michael A. Thomas, M.D.

Presenters:
Vanessa E. Cullins, M.D., M.P.H., M.B.A.
Vice President for Medical Affairs, Planned Parenthood Federation of America

Kirsten Moore, M.P.A.
President, Reproductive Health Technologies Project

Wayne C. Shields
President and CEO, Association of Reproductive Health Professionals

Sean Tipton, M.A.
Director of Public Affairs, American Society for Reproductive Medicine

NEEDS ASSESSMENT 
The development of a contraceptive agent or device takes many years to get from concept to clinical research trials to market. Many of the barriers that affect this development include the political waters that have to be traversed in order to make a particular product acceptable to a pharmaceutical company, the Food and Drug Administration, and the woman or couple that will eventually utilize the product. This symposium will examine the politics that affect contraceptive development, approval, and marketing.

LEARNING OBJECTIVES 
At the conclusion of the symposium, the attendees should be able to:

1. Determine the political influences that play a role in determining whether a contraceptive comes to market.

2. Assess the interaction between the pharmaceutical industry and legislators.

3. Determine whether the lack of tort reform in the United States has an influence on contraceptive development.

CONTRACEPTION ROUNDTABLES
Hall E 
12:15 p.m. - 1:15 p.m.

TUESDAY

T12. MALE CONTRACEPTION • Kurt T. Barnhart, M.D., M.S.C.E.

T13. CONTRACEPTIVES IN REI PRACTICE • Julia V. Johnson, M.D.

T14. SPERMICIDES: WHERE WE STAND IN 2007 • Susan A. Ballagh, M.D.

T15. THE FUTURE OF CONTRACEPTION • Clarisa R. Gracia, M.D.

CONTRACEPTION WORKSHOP
Room 201
1:30 p.m. - 2:15 p.m.

DEBATE: TREATMENT STRATEGIES FOR MENORRHAGIA AND BIRTH CONTROL IN THE MENTALLY HANDICAPPED ADOLESCENT: DEFINITIVE CONTRACEPTION VERSUS FERTILITY PRESERVING ALTERNATIVES
Joint Session presented by the Contraception SIG and the Pediatric and Adolescent Gynecology SIG

Chair: Michael A. Thomas, M.D.

Presenters: Jeffrey T. Jensen, M.D. and David M. Lee, M.D.

BREAK 2:15 p.m. - 3:00 p.m.

CONTRACEPTION ORAL ABSTRACT SESSION: 
Room 201 
3:00 p.m. - 5:00 p.m.

CONTRACEPTION SIG MEMBERS MEETING:
Room 201 
5:00 p.m. - 5:30 p.m.

CONTRACEPTION POSTER PRESENTATIONS & RECEPTION
5:30 p.m. - 7:00 p.m.

By accessing and using the ASRM Web Site, you agree to be bound by 
the ASRM Web Site Terms and Conditions of Use.  

View the ASRM Non Discrimination Policy

Copyright 1996-2008 ASRM, All Rights Reserved
American Society for Reproductive Medicine

Listed on Infertility Resources
Developed and hosted by Internet Health Resources